SHENKMAN CAPITAL MANAGEMENT INC - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6. A total of 32 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
SHENKMAN CAPITAL MANAGEMENT INC ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$8,162,000
+681.8%
4,471,000
+935.0%
0.90%
+666.9%
Q3 2014$1,044,000
-83.4%
432,000
-86.5%
0.12%
-84.1%
Q2 2014$6,290,000
-19.1%
3,200,000
-30.5%
0.74%
-12.2%
Q1 2014$7,777,000
-20.8%
4,605,000
-30.2%
0.84%
-20.4%
Q4 2013$9,814,000
+21.6%
6,595,000
+0.6%
1.06%
+12.2%
Q3 2013$8,071,000
+12.1%
6,555,000
+9.1%
0.95%
+7.9%
Q2 2013$7,197,0006,010,0000.88%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
GRACE BROTHERS MANAGEMENT LLC 2,800,000$5,117,0004.90%
SILVERBACK ASSET MANAGEMENT LLC 18,209,000$33,322,0004.30%
RAVEN ROCK CAPITAL MANAGEMENT, LLC 1,000,000$1,990,0002.80%
Verition Fund Management LLC 5,504,000$10,062,0002.26%
CAMDEN ASSET MANAGEMENT L P /CA 26,798,000$48,856,0001.81%
GUARDIAN LIFE INSURANCE CO OF AMERICA 8,600,000$15,679,0001.60%
TENOR CAPITAL MANAGEMENT Co., L.P. 3,000,000$5,490,0001.46%
BASSO CAPITAL MANAGEMENT, L.P. 4,825,000$8,782,0001.40%
Wellesley Asset Management 12,564$23,006,0001.35%
WOLVERINE ASSET MANAGEMENT LLC 31,156,000$56,979,0001.11%
View complete list of SALIX PHARMACEUTICALS INC shareholders